EU: No SPCs For New Uses OF Existing Drugs
Ruling Reverses Court’s 2012 Decision
Executive Summary
A judgment by the Court of Justice of the EU is bad news for innovators seeking supplementary protection certificates to protect new indications for their products, but it could offer new opportunities for generic firms.